Cargando…

Off the RADAR; questions regarding the trial protocol of a randomised controlled trial of antipsychotic reduction and discontinuation

The randomised controlled trial of antipsychotic reduction and discontinuation addresses essential questions with regard to continued use of antipsychotics in schizophrenia, pertaining to social functioning and continued antipsychotic use. However, significant methodological issues stated in the tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Jauhar, Sameer, Fusar-Poli, Paolo, Foreman, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101177/
https://www.ncbi.nlm.nih.gov/pubmed/36633292
http://dx.doi.org/10.1177/02698811221144633
_version_ 1785025453505904640
author Jauhar, Sameer
Fusar-Poli, Paolo
Foreman, David
author_facet Jauhar, Sameer
Fusar-Poli, Paolo
Foreman, David
author_sort Jauhar, Sameer
collection PubMed
description The randomised controlled trial of antipsychotic reduction and discontinuation addresses essential questions with regard to continued use of antipsychotics in schizophrenia, pertaining to social functioning and continued antipsychotic use. However, significant methodological issues stated in the trial protocol have the potential to confound interpretation of any findings. These include use of a non-blinded outcome measure, treatment as usual comparator and possible sample size issues.
format Online
Article
Text
id pubmed-10101177
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-101011772023-04-14 Off the RADAR; questions regarding the trial protocol of a randomised controlled trial of antipsychotic reduction and discontinuation Jauhar, Sameer Fusar-Poli, Paolo Foreman, David J Psychopharmacol Perspective The randomised controlled trial of antipsychotic reduction and discontinuation addresses essential questions with regard to continued use of antipsychotics in schizophrenia, pertaining to social functioning and continued antipsychotic use. However, significant methodological issues stated in the trial protocol have the potential to confound interpretation of any findings. These include use of a non-blinded outcome measure, treatment as usual comparator and possible sample size issues. SAGE Publications 2023-01-12 2023-04 /pmc/articles/PMC10101177/ /pubmed/36633292 http://dx.doi.org/10.1177/02698811221144633 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Perspective
Jauhar, Sameer
Fusar-Poli, Paolo
Foreman, David
Off the RADAR; questions regarding the trial protocol of a randomised controlled trial of antipsychotic reduction and discontinuation
title Off the RADAR; questions regarding the trial protocol of a randomised controlled trial of antipsychotic reduction and discontinuation
title_full Off the RADAR; questions regarding the trial protocol of a randomised controlled trial of antipsychotic reduction and discontinuation
title_fullStr Off the RADAR; questions regarding the trial protocol of a randomised controlled trial of antipsychotic reduction and discontinuation
title_full_unstemmed Off the RADAR; questions regarding the trial protocol of a randomised controlled trial of antipsychotic reduction and discontinuation
title_short Off the RADAR; questions regarding the trial protocol of a randomised controlled trial of antipsychotic reduction and discontinuation
title_sort off the radar; questions regarding the trial protocol of a randomised controlled trial of antipsychotic reduction and discontinuation
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101177/
https://www.ncbi.nlm.nih.gov/pubmed/36633292
http://dx.doi.org/10.1177/02698811221144633
work_keys_str_mv AT jauharsameer offtheradarquestionsregardingthetrialprotocolofarandomisedcontrolledtrialofantipsychoticreductionanddiscontinuation
AT fusarpolipaolo offtheradarquestionsregardingthetrialprotocolofarandomisedcontrolledtrialofantipsychoticreductionanddiscontinuation
AT foremandavid offtheradarquestionsregardingthetrialprotocolofarandomisedcontrolledtrialofantipsychoticreductionanddiscontinuation